Telomere Therapeutics

Telomere Therapeutics is a pioneering gene therapy company focused on telomere repair as a treatment for fibrosis-related diseases and other syndromes where telomeres are dysfunctional. Telomere Therapeutics is developing a therapy based on the expression of the telomerase gene through an adeno-associated viral (AAV) vector to treat idiopathic pulmonary fibrosis (IPF). This disease has no cure, is associated with high mortality, and has a median life expectancy of less than 5 years after diagnosis.